Market
Health & bioClear all
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| UrgentIQQuiet$12.0M of $12.0M · Series A · Health & bio · 506(b) · New York, NY · 2026-09-18Amended | UrgentIQAmended | Health & bio | Series A | $12.0M of $12.0MAmount sold of the amount offered as of the filing of 2026-09-29 · as of 2026-10-04How this is computed → | 2026-09-18 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | Amended |
| VicoraQuiet$2.3M of $2.5M · Seed · Health & bio · 506(b) · Buffalo, NY · 2026-09-18 | Vicora | Health & bio | Seed | $2.3M of $2.5MAmount sold of the amount offered on the filing of 2026-09-18 · as of 2026-10-04How this is computed → | 2026-09-18 | Buffalo, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Lumoptik (BrightPoint)Quiet$1.5M of $2.3M · Seed · Health & bio · 506(b) · Washington Island, WI · 2026-09-18 | Lumoptik (BrightPoint) | Health & bio | Seed | $1.5M of $2.3MAmount sold of the amount offered on the filing of 2026-09-18 · as of 2026-10-04How this is computed → | 2026-09-18 | Washington Island, WI | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Aqur BiosciencesQuiet$1.5M of $1.5M · Seed · Health & bio · 506(b) · Westlake Village, CA · 2026-09-18 | Aqur Biosciences | Health & bio | Seed | $1.5M of $1.5MAmount sold of the amount offered on the filing of 2026-09-18 · as of 2026-10-04How this is computed → | 2026-09-18 | Westlake Village, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AVAVAHiring actively$30.0M · Undisclosed · Health & bio · Boston, MA · 2026-09-17 | AVAVA | Health & bio | Undisclosed | $30.0MAmount sold on the filing of 2026-09-17 · as of 2026-10-04How this is computed → | 2026-09-17 | Boston, MA | — | 8The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| FIZE MedicalHiring actively$20.0M · Series B · Health & bio · Jericho, NY · 2026-09-17 | FIZE Medical | Health & bio | Series B | $20.0MAmount sold on the filing of 2026-09-17 · as of 2026-10-04How this is computed → | 2026-09-17 | Jericho, NY | — | 5The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Twin HealthHiring actively$59.0M of $61.5M · Series B · Health & bio · 506(b) · Menlo Park, CA · 2026-09-16AI-native | Twin HealthAI-native | Health & bio | Series B | $59.0M of $61.5MAmount sold of the amount offered on the filing of 2026-09-16 · as of 2026-10-04How this is computed → | 2026-09-16 | Menlo Park, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| XRHealthQuiet$22.8M of $22.8M · Series A · Health & bio · 506(b) · Needham, MA · 2026-09-16 | XRHealth | Health & bio | Series A | $22.8M of $22.8MAmount sold of the amount offered on the filing of 2026-09-16 · as of 2026-10-04How this is computed → | 2026-09-16 | Needham, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| XRHealth: $2.3M of $4.0M · Seed · Health & bio · 506(b) · Needham, MA · 2026-09-16 | XRHealth | Health & bio | Seed | $2.3M of $4.0MAmount sold of the amount offered on the filing of 2026-09-16 · as of 2026-10-04How this is computed → | 2026-09-16 | Needham, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| XRHealth: $2.0M of $2.0M · Seed · Health & bio · 506(b) · Needham, MA · 2026-09-10 | XRHealth | Health & bio | Seed | $2.0M of $2.0MAmount sold of the amount offered on the filing of 2026-09-10 · as of 2026-10-04How this is computed → | 2026-09-10 | Needham, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AblePay HealthQuiet$20.2M of $20.2M · Series A · Health & bio · 506(b) · Wilmington, DE · 2026-09-16 | AblePay Health | Health & bio | Series A | $20.2M of $20.2MAmount sold of the amount offered on the filing of 2026-09-16 · as of 2026-10-04How this is computed → | 2026-09-16 | Wilmington, DE | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| PeritasAIHiring actively$5.5M · Seed · Health & bio · 506(b) · Brandon, FL · 2026-09-16AI-native | PeritasAIAI-native | Health & bio | Seed | $5.5MAmount sold on the filing of 2026-09-16 · as of 2026-10-04How this is computed → | 2026-09-16 | Brandon, FL | 506(b) | 4The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Royal & Pelham, Inc.Quiet$5.4M of $7.2M · Seed · Health & bio · 506(b) · New Orleans, LA · 2026-09-15 | Royal & Pelham, Inc. | Health & bio | Seed | $5.4M of $7.2MAmount sold of the amount offered on the filing of 2026-09-15 · as of 2026-10-04How this is computed → | 2026-09-15 | New Orleans, LA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ROSE DiagnosticsQuiet$2.2M of $3.0M · Seed · Health & bio · 506(b) · Carlsbad, CA · 2026-09-15 | ROSE Diagnostics | Health & bio | Seed | $2.2M of $3.0MAmount sold of the amount offered on the filing of 2026-09-15 · as of 2026-10-04How this is computed → | 2026-09-15 | Carlsbad, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| OpZiraQuiet$2.0M of $5.0M · Seed · Health & bio · 506(b) · Middletown, PA · 2026-09-15 | OpZira | Health & bio | Seed | $2.0M of $5.0MAmount sold of the amount offered on the filing of 2026-09-15 · as of 2026-10-04How this is computed → | 2026-09-15 | Middletown, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| KeyCareHiring actively$1.7M of $5.0M · Seed · Health & bio · 506(b) · Chicago, IL · 2026-09-15 | KeyCare | Health & bio | Seed | $1.7M of $5.0MAmount sold of the amount offered on the filing of 2026-09-15 · as of 2026-10-04How this is computed → | 2026-09-15 | Chicago, IL | 506(b) | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| GevitiHiring actively$1.6M of $10.0M · Seed · Health & bio · 506(b) · Chandler, AZ · 2026-09-15 | Geviti | Health & bio | Seed | $1.6M of $10.0MAmount sold of the amount offered on the filing of 2026-09-15 · as of 2026-10-04How this is computed → | 2026-09-15 | Chandler, AZ | 506(b) | 2The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Moonwalk BiosciencesHiring actively$60.0M of $70.2M · Series B · Health & bio · 506(b) · South San Francisco, CA · 2026-09-14 | Moonwalk Biosciences | Health & bio | Series B | $60.0M of $70.2MAmount sold of the amount offered on the filing of 2026-09-14 · as of 2026-10-04How this is computed → | 2026-09-14 | South San Francisco, CA | 506(b) | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Tempo TherapeuticsHiring actively$14.0M of $14.5M · Series A · Health & bio · 506(b) · San Diego, CA · 2026-09-11 | Tempo Therapeutics | Health & bio | Series A | $14.0M of $14.5MAmount sold of the amount offered on the filing of 2026-09-11 · as of 2026-10-04How this is computed → | 2026-09-11 | San Diego, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Nexalis Health, Inc.Quiet$3.6M of $3.6M · Seed · Health & bio · 506(b) · Edgemont, PA · 2026-09-11 | Nexalis Health, Inc. | Health & bio | Seed | $3.6M of $3.6MAmount sold of the amount offered on the filing of 2026-09-11 · as of 2026-10-04How this is computed → | 2026-09-11 | Edgemont, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Retham TechnologiesQuiet$1.1M of $1.5M · Pre-seed · Health & bio · 506(b) · Wauwatosa, WI · 2026-09-11 | Retham Technologies | Health & bio | Pre-seed | $1.1M of $1.5MAmount sold of the amount offered on the filing of 2026-09-11 · as of 2026-10-04How this is computed → | 2026-09-11 | Wauwatosa, WI | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Septablate, Inc.Quiet$1.0M of $4.5M · Pre-seed · Health & bio · 506(b) · Minnetonka, MN · 2026-09-11 | Septablate, Inc. | Health & bio | Pre-seed | $1.0M of $4.5MAmount sold of the amount offered on the filing of 2026-09-11 · as of 2026-10-04How this is computed → | 2026-09-11 | Minnetonka, MN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AlzheonQuiet$78.8M of $500M · Series C+ · Health & bio · 506(b) · Framingham, MA · 2026-09-10 | Alzheon | Health & bio | Series C+ | $78.8M of $500MAmount sold of the amount offered on the filing of 2026-09-10 · as of 2026-10-04How this is computed → | 2026-09-10 | Framingham, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Prosper HealthHiring actively$10.0M of $10.0M · Series A · Health & bio · 506(b) · Weston, FL · 2026-09-10 | Prosper Health | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-09-10 · as of 2026-10-04How this is computed → | 2026-09-10 | Weston, FL | 506(b) | 64The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| ClinwareQuiet$4.9M of $5.0M · Seed · Health & bio · 506(c) · Apex, NC · 2026-09-10AI-native | ClinwareAI-native | Health & bio | Seed | $4.9M of $5.0MAmount sold of the amount offered on the filing of 2026-09-10 · as of 2026-10-04How this is computed → | 2026-09-10 | Apex, NC | 506(c) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| Parasol MedtechQuiet$2.4M of $2.5M · Seed · Health & bio · 506(b) · Hinsdale, IL · 2026-09-10 | Parasol Medtech | Health & bio | Seed | $2.4M of $2.5MAmount sold of the amount offered on the filing of 2026-09-10 · as of 2026-10-04How this is computed → | 2026-09-10 | Hinsdale, IL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| CoologicsQuiet$1.0M of $2.5M · Pre-seed · Health & bio · 506(b) · Grove City, OH · 2026-09-10 | Coologics | Health & bio | Pre-seed | $1.0M of $2.5MAmount sold of the amount offered on the filing of 2026-09-10 · as of 2026-10-04How this is computed → | 2026-09-10 | Grove City, OH | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Iambic TherapeuticsHiring actively$66.0M of $66.5M · Series C+ · Health & bio · 506(b) · San Diego, CA · 2026-09-09AI-native | Iambic TherapeuticsAI-native | Health & bio | Series C+ | $66.0M of $66.5MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | San Diego, CA | 506(b) | 32The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Airway TherapeuticsHiring actively$43.5M of $50.6M · Series B · Health & bio · 506(b) · Marietta, GA · 2026-09-09 | Airway Therapeutics | Health & bio | Series B | $43.5M of $50.6MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | Marietta, GA | 506(b) | 2The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Cloverleaf BioQuiet$14.8M of $29.6M · Series A · Health & bio · 506(b) · New Haven, CT · 2026-09-09 | Cloverleaf Bio | Health & bio | Series A | $14.8M of $29.6MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | New Haven, CT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Animal BioscienceQuiet$2.3M of $2.6M · Seed · Health & bio · 506(b) · Boston, MA · 2026-09-09 | Animal Bioscience | Health & bio | Seed | $2.3M of $2.6MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| RightwayQuiet$155M of $155M · Series E · Health & bio · 506(b) · New York, NY · 2026-09-08 | Rightway | Health & bio | Series E | $155M of $155MAmount sold of the amount offered on the filing of 2026-09-08 · as of 2026-10-04How this is computed → | 2026-09-08 | New York, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Ellipsys MedicalQuiet$8.1M of $10.8M · Seed · Health & bio · 506(b) · San Clemente, CA · 2026-09-08Amended | Ellipsys MedicalAmended | Health & bio | Seed | $8.1M of $10.8MAmount sold of the amount offered as of the filing of 2026-09-29 · as of 2026-10-04How this is computed → | 2026-09-08 | San Clemente, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | Amended |
| MalcovaQuiet$1.2M of $2.0M · Pre-seed · Health & bio · 506(b) · Newark, CA · 2026-09-08 | Malcova | Health & bio | Pre-seed | $1.2M of $2.0MAmount sold of the amount offered on the filing of 2026-09-08 · as of 2026-10-04How this is computed → | 2026-09-08 | Newark, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| SonaQuiet$1.0M of $1.0M · Pre-seed · Health & bio · 506(b) · Stoughton, MA · 2026-09-08 | Sona | Health & bio | Pre-seed | $1.0M of $1.0MAmount sold of the amount offered on the filing of 2026-09-08 · as of 2026-10-04How this is computed → | 2026-09-08 | Stoughton, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ImmunophotonicsQuiet$10.1M · Series A · Health & bio · 506(b) · St. Louis, MO · 2026-09-04 | Immunophotonics | Health & bio | Series A | $10.1MAmount sold on the filing of 2026-09-04 · as of 2026-10-04How this is computed → | 2026-09-04 | St. Louis, MO | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Episteme PrognosticsQuiet$5.1M of $6.0M · Seed · Health & bio · 506(b) · Brooklyn, NY · 2026-09-04Amended | Episteme PrognosticsAmended | Health & bio | Seed | $5.1M of $6.0MAmount sold of the amount offered as of the filing of 2026-09-04 · as of 2026-10-04How this is computed → | 2026-09-04 | Brooklyn, NY | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | Amended |
| TechNovaTimeHiring actively$3.3M of $3.3M · Seed · Health & bio · 506(b) · Pompton Lakes, NJ · 2026-09-04AI-native | TechNovaTimeAI-native | Health & bio | Seed | $3.3M of $3.3MAmount sold of the amount offered on the filing of 2026-09-04 · as of 2026-10-04How this is computed → | 2026-09-04 | Pompton Lakes, NJ | 506(b) | 4The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Superluminal MedicinesQuiet$65.5M of $65.5M · Series C+ · Health & bio · 506(b) · Boston, MA · 2026-09-03AI-native | Superluminal MedicinesAI-native | Health & bio | Series C+ | $65.5M of $65.5MAmount sold of the amount offered on the filing of 2026-09-03 · as of 2026-10-04How this is computed → | 2026-09-03 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| Dravite Therapeutics, Inc.Quiet$53.0M of $53.0M · Series B · Health & bio · 506(b) · San Francisco, CA · 2026-09-03 | Dravite Therapeutics, Inc. | Health & bio | Series B | $53.0M of $53.0MAmount sold of the amount offered on the filing of 2026-09-03 · as of 2026-10-04How this is computed → | 2026-09-03 | San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| OpynQuiet$4.5M of $5.0M · Seed · Health & bio · 506(b) · Conshohocken, PA · 2026-09-03AI-native | OpynAI-native | Health & bio | Seed | $4.5M of $5.0MAmount sold of the amount offered on the filing of 2026-09-03 · as of 2026-10-04How this is computed → | 2026-09-03 | Conshohocken, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| Zing HealthQuiet$22.5M of $30.0M · Series A · Health & bio · 506(b) · Chicago, IL · 2026-09-02 | Zing Health | Health & bio | Series A | $22.5M of $30.0MAmount sold of the amount offered on the filing of 2026-09-02 · as of 2026-10-04How this is computed → | 2026-09-02 | Chicago, IL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet |